Sociedad Americana de Hirudoterapia

Medicinal leech therapy in pain syndromes: a narrative review

Narrative review published in Wiener Medizinische Wochenschrift (2013)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewEnsayos clínicosFarmacología salivalKoeppen D et al. · Wiener Medizinische Wochenschrift, 2013

Abstract

Medicinal leech therapy is used in a variety of conditions; most of which have pain as a major symptom. Its mode of action relies on the injection of leech saliva into patients' tissues during the process of blood withdrawal. Leech saliva contains active ingredients with anti-inflammatory, thrombolytic, anti-coagulant and blood- and lymph-circulation enhancing properties. A specific analgesic substance within the leech saliva is yet to be identified. Pain relief from leech therapy is rapid, effective and long-lasting in many conditions. This review compiles studies and case reports that provide clinical evidence for leech therapy's analgesic effects.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAnimalsChronic PainEdemaHematomaHumansLeechesLeechingOsteoarthritisPalliative CareRandomized Controlled Trials as TopicSalivaTennis Elbow

Resumen

Narrative review on leech therapy's analgesic effect across multiple pain syndromes (osteoarthritis, epicondylitis, hematoma, thrombophlebitis, varicose veins); the saliva contains anti-inflammatory, thrombolytic, anti-coagulant and circulation-enhancing molecules, though a specific analgesic compound has not been identified.

Por qué esto importa para la hirudoterapia

Synthesizes evidence for the underexplored analgesic action of leech saliva.

Citación

Medicinal leech therapy in pain syndromes: a narrative review.

Koeppen D et al. · Wiener Medizinische Wochenschrift, 2013

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.